Evidence map›Paper›PMID 35120524›Full record

ArticleMolecular neurodegeneration2022

Differential regulation of progranulin derived granulin peptides.

Tingting Zhang, Huan Du, Mariela Nunez Santos, Xiaochun Wu, Mitchell D Pagan, Lianne Jillian Trigiani, Nozomi Nishimura, Thomas Reinheckel, Fenghua Hu

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Tingting ZhangDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
Huan DuDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
Mariela Nunez SantosDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
Xiaochun WuDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
Mitchell D PaganDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
Lianne Jillian TrigianiNancy E. and Peter C. Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.
Nozomi NishimuraNancy E. and Peter C. Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.
Thomas ReinheckelInstitute of Molecular Medicine and Cell Research, Medical Faculty and BIOSS Centre for Biological Signaling Studies, Albert-Ludwigs-University Freiburg, 79104, Freiburg, Germany.
Fenghua HuDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA. fh87@cornell.edu.ORCID http://orcid.org/0000-0002-6447-9992
Cornell University · USUniversity of Freiburg · DE

Funding

Lysosomal Function of Progranulin and NeurodegenerationR01NS095954 · NINDS · CORNELL UNIVERSITY · PI Fenghua Hu · 2017 to 2026
$4.9M
Function of TMEM106B in NeurodegenerationR01NS088448 · NINDS · CORNELL UNIVERSITY · PI HU, FENGHUA · 2014 to 2025
$4.2M
NINDS NIH HHS R01 NS088448NINDS NIH HHS R01 NS095954
6 · The paper itself

Abstract

backgroundHaploinsufficiency of progranulin (PGRN) is a leading cause of frontotemporal lobar degeneration (FTLD). PGRN is comprised of 7.5 granulin repeats and is processed into individual granulin peptides in the lysosome. However, very little is known about the levels and regulations of individual granulin peptides due to the lack of specific antibodies.

resultsHere we report the generation and characterization of antibodies specific to each granulin peptide. We found that the levels of granulins C, E and F are regulated differently  compared to granulins A and B in various tissues. The levels of PGRN and granulin peptides vary in different brain regions and the ratio between granulins and PGRN is highest in the cortical region in the adult male mouse brain. Granulin-A is localized in the lysosome in both neurons and microglia and its levels in microglia increase under pathological conditions. Interestingly,  the levels of granulin A in microglia change correspondingly with PGRN in response to stroke but not demyelination. Furthermore, deficiency of lysosomal proteases and the PGRN binding partner prosaposin leads to alterations in the ratios between individual granulin peptides. Granulins B, C and E are heavily glycosylated and the glycosylation patterns can be regulated.

conclusionOur results support that the levels of individual granulin peptides are differentially regulated under physiological and pathological conditions and provide novel insights into how granulin peptides function in the lysosome.

Indexed as

Frontotemporal Lobar DegenerationIntercellular Signaling Peptides and ProteinsAnimalsGranulinsLysosomesMaleMiceProgranulinsGranulinsIntercellular Signaling Peptides and ProteinsProgranulinsCathepsinFrontotemporal lobar degeneration (FTLD)GlycosylationGranulinLysosomeProgranulin (PGRN)

Identifiers

PMID35120524
PMCPMC8815130
OpenAlexW4220846387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.